The marine pharmaceuticals market size is estimated to increase by USD 1.56 billion from 2021 to 2026, with a CAGR of 7.73%, according to a recent market study by Technavio. Licensing agreements will drive market growth during the forecast period. These agreements enable companies to expand their reach to multiple countries with relatively low risk. For instance, PharmaMar has a licensing agreement with Boryung Pharm for Zepsyre (lurbinectedin) in South Korea. This agreement will enable the entry of Zepsyre into the South Korean market. Similarly, the licensing and marketing agreement between PharmaMar and STA will allow the entry of lurbinectedin into Australia, New Zealand, and several Asian countries. Such agreements will increase the availability of marine pharmaceuticals across the world, which, in turn, will fuel the global market growth during the forecast period. Discover more insights on market size before buying the full report – Request a sample report
Chart & data table on market size, comparative analysis of segments, and Y-O-Y growth of marine pharmaceuticals market
- The market is segmented by product into oncology, cardiovascular, anti-infectives, and others).
- Based on product, the oncology segment will account for a significant share of market growth during the forecast period. Cancer is one of the main causes of death globally. As a result, there is a crucial need for novel oncology drugs. Thus, the high incidence of various types of cancers worldwide will increase the demand for marine oncology products. Thus, the increasing demand for oncology drugs will drive market growth during the forecast period.
To procure the data – Buy report!
Chart & data table on market size analysis of key countries
- The market is segmented by region North America, Europe, Asia, and Rest of World (ROW). An analysis of key leading countries has been included.
- Based on geography, North America will account for 38% of the market’s growth during the forecast period. The US and Canada are the key contributors to the marine pharmaceuticals market in the region. Moreover, market growth in North America will be faster than the growth of the market in Rest of World (ROW). The high prevalence of elevated TG levels will drive market growth in the region during the forecast period.
For Insights on the market dynamics & segmentations, View a PDF Sample !
The report also offers information on the criticality of inputs, R&D, CAPEX, technology, and products of vendors listed below –
- Amway Corp.
- BASF SE
- BeyondSpring Inc.
- BioMarin Pharmaceutical Inc.
- Bristol Myers Squibb Co.
- Eisai Co. Ltd.
- GlaxoSmithKline Plc
- Guardian Industries Corp.
- Jazz Pharmaceuticals Plc
- Koninklijke DSM NV
- Merck KGaA
- Nordic Naturals Inc.
- Pelagia EPAX
- Pfizer Inc.
- Pharma Marine AS
- PharmaMar SA
- Seagen Inc.
- Croda International Plc
Market dynamics
Marine peptides have anti-infective properties, which is a key trend in the market. Researchers are evaluating the potential of peptides from marine sources as anti-infective agents. Marine-derived peptides are specific fragments of protein that act as sources of nitrogen and amino acids. They have various potential physiological functions. Fish, algae, crabs, marine bacteria, and fungi are the primary sources of marine peptides. The discovery of new anti-infectives to cater to the demand for new and efficacious antimicrobial compounds will support market growth during the forecast period.
The regular supply of marine organisms and compounds is challenging market growth. For example, sponges produce numerous bioactive metabolites, which serve as a chemical defense to combat environmental stress factors. One of the issues related to the supply of raw materials required for marine pharmaceutical products is the non-availability of efficient technology for extraction. Moreover, the preservation of the compounds obtained is a challenge. Another hurdle is supply feasibility in an economical and eco-friendly manner. This makes it difficult to maintain a regular supply of marine-derived pharmaceutical compounds. Such factors will hinder market growth during the forecast period.
What are the key data covered in this marine pharmaceuticals market report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the marine pharmaceuticals market between 2022 and 2026
- Precise estimation of the size of the marine pharmaceuticals market and its contribution to the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the marine pharmaceuticals market across North America, Europe, Asia, and Rest of World (ROW)
- A thorough analysis of the market’s competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of marine pharmaceuticals market vendors
Related Reports:
The pharmaceutical traceability market size is expected to increase by USD 9.37 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 20.02%. Furthermore, this report extensively covers pharmaceutical traceability market segmentation by type (barcode, RFID, GPS, and others) and geography (North America, Europe, Asia, and the Rest of the World (ROW)).
The pharmaceutical contract research and manufacturing market is estimated to grow at a CAGR of 10.32% between 2022 and 2027. The market size is forecasted to increase by USD 121.35 billion. This market report extensively covers market segmentation by service (CMO and CRO), end-user (big pharmaceuticals, small and medium-sized pharmaceuticals, and generic pharmaceuticals), and geography (North America, Asia, Europe, and Rest Of World (ROW)).
Gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform
| Marine Pharmaceuticals Market Scope | |
| Report Coverage | Details |
| Base year | 2021 |
| Forecast period | 2022-2026 |
| Growth momentum & CAGR | Accelerate at a CAGR of 7.73% |
| Market growth 2022-2026 | USD 1.56 billion |
| Market structure | Concentrated |
| YoY growth 2021-2022 (%) | 5.3 |
| Regional analysis | North America, Europe, Asia, and Rest of World (ROW) |
| Performing market contribution | North America at 38% |
| Key countries | US, Canada, Germany, UK, and China |
| Competitive landscape | Leading vendors, market positioning of vendors, competitive strategies, and industry risks |
| Key companies profiled | Amway Corp., BASF SE, BeyondSpring Inc., BioMarin Pharmaceutical Inc., Bristol Myers Squibb Co., Eisai Co. Ltd., GlaxoSmithKline Plc, Guardian Industries Corp., Jazz Pharmaceuticals Plc, Koninklijke DSM NV, Merck KGaA, Nordic Naturals Inc., Pelagia EPAX, Pfizer Inc., Pharma Marine AS, PharmaMar SA, Seagen Inc., and Croda International Plc |
| Market dynamics | Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period. |
| Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Browse for Technavio Health Care market reports
Table of contents
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
5 Market Segmentation by Product
- 5.1 Market segments
- Exhibit 24: Chart on Product – Market share 2021-2026 (%)
- Exhibit 25: Data Table on Product – Market share 2021-2026 (%)
- 5.2 Comparison by Product
- Exhibit 26: Chart on Comparison by Product
- Exhibit 27: Data Table on Comparison by Product
- 5.3 Oncology – Market size and forecast 2021-2026
- Exhibit 28: Chart on Oncology – Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Oncology – Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Oncology – Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Oncology – Year-over-year growth 2021-2026 (%)
- 5.4 Cardiovascular – Market size and forecast 2021-2026
- Exhibit 32: Chart on Cardiovascular – Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Cardiovascular – Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Cardiovascular – Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Cardiovascular – Year-over-year growth 2021-2026 (%)
- 5.5 Anti-infectives – Market size and forecast 2021-2026
- Exhibit 36: Chart on Anti-infectives – Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Anti-infectives – Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Anti-infectives – Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Anti-infectives – Year-over-year growth 2021-2026 (%)
- 5.6 Others – Market size and forecast 2021-2026
- Exhibit 40: Chart on Others – Market size and forecast 2021-2026 ($ million)
- Exhibit 41: Data Table on Others – Market size and forecast 2021-2026 ($ million)
- Exhibit 42: Chart on Others – Year-over-year growth 2021-2026 (%)
- Exhibit 43: Data Table on Others – Year-over-year growth 2021-2026 (%)
- 5.7 Market opportunity by Product
- Exhibit 44: Market opportunity by Product ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 46: Chart on Market share by geography 2021-2026 (%)
- Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 48: Chart on Geographic comparison
- Exhibit 49: Data Table on Geographic comparison
- 7.3 North America – Market size and forecast 2021-2026
- Exhibit 50: Chart on North America – Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on North America – Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on North America – Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on North America – Year-over-year growth 2021-2026 (%)
- 7.4 Europe – Market size and forecast 2021-2026
- Exhibit 54: Chart on Europe – Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Europe – Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Europe – Year-over-year growth 2021-2026 (%)
- 7.5 Asia – Market size and forecast 2021-2026
- Exhibit 58: Chart on Asia – Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Asia – Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Asia – Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
- Exhibit 62: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
- 7.7 US – Market size and forecast 2021-2026
- Exhibit 66: Chart on US – Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on US – Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on US – Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on US – Year-over-year growth 2021-2026 (%)
- 7.8 Germany – Market size and forecast 2021-2026
- Exhibit 70: Chart on Germany – Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Germany – Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Germany – Year-over-year growth 2021-2026 (%)
- 7.9 China – Market size and forecast 2021-2026
- Exhibit 74: Chart on China – Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on China – Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on China – Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on China – Year-over-year growth 2021-2026 (%)
- 7.10 UK – Market size and forecast 2021-2026
- Exhibit 78: Chart on UK – Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on UK – Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on UK – Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on UK – Year-over-year growth 2021-2026 (%)
- 7.11 Canada – Market size and forecast 2021-2026
- Exhibit 82: Chart on Canada – Market size and forecast 2021-2026 ($ million)
- Exhibit 83: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
- Exhibit 84: Chart on Canada – Year-over-year growth 2021-2026 (%)
- Exhibit 85: Data Table on Canada – Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 86: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 87: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 89: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 90: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 91: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 92: Matrix on vendor position and classification
- 10.3 BeyondSpring Inc.
- Exhibit 93: BeyondSpring Inc. – Overview
- Exhibit 94: BeyondSpring Inc. – Product / Service
- Exhibit 95: BeyondSpring Inc. – Key offerings
- 10.4 BioMarin Pharmaceutical Inc.
- Exhibit 96: BioMarin Pharmaceutical Inc. – Overview
- Exhibit 97: BioMarin Pharmaceutical Inc. – Product / Service
- Exhibit 98: BioMarin Pharmaceutical Inc. – Key offerings
- 10.5 Bristol Myers Squibb Co.
- Exhibit 99: Bristol Myers Squibb Co. – Overview
- Exhibit 100: Bristol Myers Squibb Co. – Product / Service
- Exhibit 101: Bristol Myers Squibb Co. – Key offerings
- 10.6 Eisai Co. Ltd.
- Exhibit 102: Eisai Co. Ltd. – Overview
- Exhibit 103: Eisai Co. Ltd. – Business segments
- Exhibit 104: Eisai Co. Ltd. – Key offerings
- Exhibit 105: Eisai Co. Ltd. – Segment focus
- 10.7 GlaxoSmithKline Plc
- Exhibit 106: GlaxoSmithKline Plc – Overview
- Exhibit 107: GlaxoSmithKline Plc – Business segments
- Exhibit 108: GlaxoSmithKline Plc – Key news
- Exhibit 109: GlaxoSmithKline Plc – Key offerings
- Exhibit 110: GlaxoSmithKline Plc – Segment focus
- 10.8 Jazz Pharmaceuticals Plc
- Exhibit 111: Jazz Pharmaceuticals Plc – Overview
- Exhibit 112: Jazz Pharmaceuticals Plc – Product / Service
- Exhibit 113: Jazz Pharmaceuticals Plc – Key news
- Exhibit 114: Jazz Pharmaceuticals Plc – Key offerings
- 10.9 Nordic Naturals Inc.
- Exhibit 115: Nordic Naturals Inc. – Overview
- Exhibit 116: Nordic Naturals Inc. – Product / Service
- Exhibit 117: Nordic Naturals Inc. – Key offerings
- 10.10 Pfizer Inc.
- Exhibit 118: Pfizer Inc. – Overview
- Exhibit 119: Pfizer Inc. – Product / Service
- Exhibit 120: Pfizer Inc. – Key news
- Exhibit 121: Pfizer Inc. – Key offerings
- 10.11 PharmaMar SA
- Exhibit 122: PharmaMar SA – Overview
- Exhibit 123: PharmaMar SA – Business segments
- Exhibit 124: PharmaMar SA – Key news
- Exhibit 125: PharmaMar SA – Key offerings
- Exhibit 126: PharmaMar SA – Segment focus
- 10.12 Seagen Inc.
- Exhibit 127: Seagen Inc. – Overview
- Exhibit 128: Seagen Inc. – Product / Service
- Exhibit 129: Seagen Inc. – Key offerings
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 130: Inclusions checklist
- Exhibit 131: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 132: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 133: Research methodology
- Exhibit 134: Validation techniques employed for market sizing
- Exhibit 135: Information sources
- 11.5 List of abbreviations
- Exhibit 136: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
